GSK, Teva Urge 3rd Circ. To Nix Lamictal Class Cert.
GlaxoSmithKline PLC and Teva Pharmaceuticals Ltd. urged the Third Circuit to decertify a class of drug wholesalers claiming the drugmakers colluded to delay generic competition for the mood stabilizer Lamictal, arguing...To view the full article, register now.
Already a subscriber? Click here to view full article